organization · Reporting owner

H&F Executives VIII, L.P.

Disclosed activity across 3 companies

Tapewire entity: 73137
SEC CIK: 0001619367

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Claritev CorpCTEV · Entity 5238	10% owner	November 12, 2025	November 14, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Claritev Corp

Report date November 12, 2025 · Filed November 14, 2025

Jointly reported with H&F Corporate Investors VIII, Ltd., Hellman & Friedman Investors VIII, L.P., Hellman & Friedman Capital Partners VIII, L.P., Hellman & Friedman Capital Partners VIII (Parallel), L.P., HFCP VIII (Parallel - A), L.P., H&F Associates VIII, L.P., H&F Polaris Partners, L.P., H&F Polaris Partners GP, LLC

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	2,024,899	Reported balance After 2025-11-12 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2025-11-12 · Sale · Disposed 789,936 · Balance 2,024,899 F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F2: Represents shares sold directly by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	908,778	Reported balance After 2025-11-12 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2025-11-12 · Sale · Disposed 354,524 · Balance 908,778 F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F3: Represents shares sold directly by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	171,740	Reported balance After 2025-11-12 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2025-11-12 · Sale · Disposed 66,997 · Balance 171,740 F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F4: Represents shares sold directly by HFCP VIII Parallel-A ("HFCP VIII Parallel-A"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	53,118	Reported balance After 2025-11-12 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2025-11-12 · Sale · Disposed 20,722 · Balance 53,118 F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F5: Represents shares sold directly by H&F Executives VIII, L.P. ("H&F VIII Executives"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	8,932	Reported balance After 2025-11-12 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2025-11-12 · Sale · Disposed 3,485 · Balance 8,932 F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F6: Represents shares sold directly by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein.
Class A Common StockSEC Table I · non-derivative	IndirectSee Footnotes	677,590	Reported balance After 2025-11-12 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2025-11-12 · Sale · Disposed 264,336 · Balance 677,590 F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F7: Represents shares sold directly by H&F Polaris Partners, L.P. ("Polaris Partners"), the general partner of which is H&F Polaris Partners GP, LLC, the managing member of which is HFCP VIII. F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions.

F2: Represents shares sold directly by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII").

F3: Represents shares sold directly by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel").

F4: Represents shares sold directly by HFCP VIII Parallel-A ("HFCP VIII Parallel-A").

F5: Represents shares sold directly by H&F Executives VIII, L.P. ("H&F VIII Executives").

F6: Represents shares sold directly by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds").

F7: Represents shares sold directly by H&F Polaris Partners, L.P. ("Polaris Partners"), the general partner of which is H&F Polaris Partners GP, LLC, the managing member of which is HFCP VIII.

F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

PPD, Inc.

Report date December 08, 2021 · Filed December 08, 2021

Section 16 reporting ended · disclosed 2021-12-08. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2021-12-08 · Sale · Disposed 52,884,036 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F2: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2021-12-08 · Sale · Disposed 20,244,387 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F3: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2021-12-08 · Sale · Disposed 3,630,740 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F4: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2021-12-08 · Sale · Disposed 359,372 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F5: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2021-12-08 · Sale · Disposed 35,622,429 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F6: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2021-12-08 · Sale · Disposed 15,987,409 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F7: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 7 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 7 · 2021-12-08 · Sale · Disposed 3,021,286 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F8: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 8 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 8 · 2021-12-08 · Sale · Disposed 934,469 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F9: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2021-12-08 transaction · row 9 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 9 · 2021-12-08 · Sale · Disposed 157,138 · Balance 0 F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F10: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.

Filing footnotes · ownership attribution and instrument terms

F1: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash.

F2: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII").

F3: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel").

F4: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A").

F5: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds").

F6: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII").

F7: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel").

F8: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A").

F9: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives").

F10: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds").

F11: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII.

Snap One Holdings Corp.

Report date June 14, 2024 · Filed June 14, 2024

Jointly reported with H&F Corporate Investors VIII, Ltd., Hellman & Friedman Investors VIII, L.P., Hellman & Friedman Capital Partners VIII, L.P., Hellman & Friedman Capital Partners VIII (Parallel), L.P., HFCP VIII (Parallel - A), L.P., H&F Associates VIII, L.P., H&F Copper Holdings VIII, L.P., H&F Copper Holdings VIII GP, LLC

Section 16 reporting ended · disclosed 2024-06-14. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2024-06-14 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2024-06-14 · Other · Disposed 23,854,976 · Balance 0 F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F2: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2024-06-14 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2024-06-14 · Other · Disposed 10,706,163 · Balance 0 F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F3: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2024-06-14 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2024-06-14 · Other · Disposed 2,023,312 · Balance 0 F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F4: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2024-06-14 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2024-06-14 · Other · Disposed 607,517 · Balance 0 F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F5: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2024-06-14 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2024-06-14 · Other · Disposed 124,638 · Balance 0 F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F6: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein.
Common StockSEC Table I · non-derivative	IndirectSee Footnotes	Reported balance After 2024-06-14 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2024-06-14 · Other · Disposed 18,107,829 · Balance 0 F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F7: Reflects securities directly held by H&F Copper Holdings VIII, L.P. ("Copper Holdings"), the general partner of which is H&F Copper Holdings VIII GP, LLC, the managing member of which is HFCP VIII. F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein.

Filing footnotes · ownership attribution and instrument terms

F1: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes.

F2: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII").

F3: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel").

F4: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A").

F5: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives").

F6: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds").

F7: Reflects securities directly held by H&F Copper Holdings VIII, L.P. ("Copper Holdings"), the general partner of which is H&F Copper Holdings VIII GP, LLC, the managing member of which is HFCP VIII.

F8: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
November 12, 2025 Filed Nov 14, 2025 21:30 UTC	Claritev Corp CTEV · Entity 5238	SaleClass A Common Stock	264,336	$48.67	$12,864,572.28	Disclosure SEC source: 0001193125-25-283138 · ownership.xml · nonDerivative · entry 6 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Polaris Partners, L.P. · CIK 0001677346 · 10% owner H&F Polaris Partners GP, LLC · CIK 0001827933 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 677,590 F1 · price: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F7 · ownership.nature: Represents shares sold directly by H&F Polaris Partners, L.P. ("Polaris Partners"), the general partner of which is H&F Polaris Partners GP, LLC, the managing member of which is HFCP VIII. F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document
November 12, 2025 Filed Nov 14, 2025 21:30 UTC	Claritev Corp CTEV · Entity 5238	SaleClass A Common Stock	3,485	$48.67	$169,606.24	Disclosure SEC source: 0001193125-25-283138 · ownership.xml · nonDerivative · entry 5 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Polaris Partners, L.P. · CIK 0001677346 · 10% owner H&F Polaris Partners GP, LLC · CIK 0001827933 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 8,932 F1 · price: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F6 · ownership.nature: Represents shares sold directly by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document
November 12, 2025 Filed Nov 14, 2025 21:30 UTC	Claritev Corp CTEV · Entity 5238	SaleClass A Common Stock	20,722	$48.67	$1,008,487.94	Disclosure SEC source: 0001193125-25-283138 · ownership.xml · nonDerivative · entry 4 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Polaris Partners, L.P. · CIK 0001677346 · 10% owner H&F Polaris Partners GP, LLC · CIK 0001827933 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 53,118 F1 · price: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F5 · ownership.nature: Represents shares sold directly by H&F Executives VIII, L.P. ("H&F VIII Executives"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document
November 12, 2025 Filed Nov 14, 2025 21:30 UTC	Claritev Corp CTEV · Entity 5238	SaleClass A Common Stock	66,997	$48.67	$3,260,576.50	Disclosure SEC source: 0001193125-25-283138 · ownership.xml · nonDerivative · entry 3 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Polaris Partners, L.P. · CIK 0001677346 · 10% owner H&F Polaris Partners GP, LLC · CIK 0001827933 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 171,740 F1 · price: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F4 · ownership.nature: Represents shares sold directly by HFCP VIII Parallel-A ("HFCP VIII Parallel-A"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document
November 12, 2025 Filed Nov 14, 2025 21:30 UTC	Claritev Corp CTEV · Entity 5238	SaleClass A Common Stock	354,524	$48.67	$17,253,796.77	Disclosure SEC source: 0001193125-25-283138 · ownership.xml · nonDerivative · entry 2 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Polaris Partners, L.P. · CIK 0001677346 · 10% owner H&F Polaris Partners GP, LLC · CIK 0001827933 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 908,778 F1 · price: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F3 · ownership.nature: Represents shares sold directly by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document
November 12, 2025 Filed Nov 14, 2025 21:30 UTC	Claritev Corp CTEV · Entity 5238	SaleClass A Common Stock	789,936	$48.67	$38,444,210.28	Disclosure SEC source: 0001193125-25-283138 · ownership.xml · nonDerivative · entry 1 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Polaris Partners, L.P. · CIK 0001677346 · 10% owner H&F Polaris Partners GP, LLC · CIK 0001827933 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 2,024,899 F1 · price: The shares of Class A common stock were sold in connection with an underwritten public offering of the Issuer. The shares were sold at a price per share equal to the public offering price, net of underwriting discounts and commissions. F2 · ownership.nature: Represents shares sold directly by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Polaris Partners. The Reporting Persons states that this filing shall not be an admission that the Reporting Persons are the beneficial owners of any of the securities reported herein, and each Reporting Person disclaims beneficial ownership of such securities except to the extent of such Reporting Person's pecuniary interest therein. Read SEC document
June 14, 2024 Filed Jun 14, 2024 17:00 UTC	Snap One Holdings Corp. SNPO · Entity 89862	OtherCommon Stock	18,107,829	$10.75	$194,659,161.75	Disclosure SEC source: 0000950170-24-073773 · ownership.xml · nonDerivative · entry 6 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Copper Holdings VIII, L.P. · CIK 0001871642 · 10% owner H&F Copper Holdings VIII GP, LLC · CIK 0001871641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F1 · price: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F7 · ownership.nature: Reflects securities directly held by H&F Copper Holdings VIII, L.P. ("Copper Holdings"), the general partner of which is H&F Copper Holdings VIII GP, LLC, the managing member of which is HFCP VIII. F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. Read SEC document
June 14, 2024 Filed Jun 14, 2024 17:00 UTC	Snap One Holdings Corp. SNPO · Entity 89862	OtherCommon Stock	124,638	$10.75	$1,339,858.50	Disclosure SEC source: 0000950170-24-073773 · ownership.xml · nonDerivative · entry 5 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Copper Holdings VIII, L.P. · CIK 0001871642 · 10% owner H&F Copper Holdings VIII GP, LLC · CIK 0001871641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F1 · price: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F6 · ownership.nature: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. Read SEC document
June 14, 2024 Filed Jun 14, 2024 17:00 UTC	Snap One Holdings Corp. SNPO · Entity 89862	OtherCommon Stock	607,517	$10.75	$6,530,807.75	Disclosure SEC source: 0000950170-24-073773 · ownership.xml · nonDerivative · entry 4 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Copper Holdings VIII, L.P. · CIK 0001871642 · 10% owner H&F Copper Holdings VIII GP, LLC · CIK 0001871641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F1 · price: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F5 · ownership.nature: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. Read SEC document
June 14, 2024 Filed Jun 14, 2024 17:00 UTC	Snap One Holdings Corp. SNPO · Entity 89862	OtherCommon Stock	2,023,312	$10.75	$21,750,604.00	Disclosure SEC source: 0000950170-24-073773 · ownership.xml · nonDerivative · entry 3 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Copper Holdings VIII, L.P. · CIK 0001871642 · 10% owner H&F Copper Holdings VIII GP, LLC · CIK 0001871641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F1 · price: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F4 · ownership.nature: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. Read SEC document
June 14, 2024 Filed Jun 14, 2024 17:00 UTC	Snap One Holdings Corp. SNPO · Entity 89862	OtherCommon Stock	10,706,163	$10.75	$115,091,252.25	Disclosure SEC source: 0000950170-24-073773 · ownership.xml · nonDerivative · entry 2 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Copper Holdings VIII, L.P. · CIK 0001871642 · 10% owner H&F Copper Holdings VIII GP, LLC · CIK 0001871641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F1 · price: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F3 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. Read SEC document
June 14, 2024 Filed Jun 14, 2024 17:00 UTC	Snap One Holdings Corp. SNPO · Entity 89862	OtherCommon Stock	23,854,976	$10.75	$256,440,992.00	Disclosure SEC source: 0000950170-24-073773 · ownership.xml · nonDerivative · entry 1 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner H&F Copper Holdings VIII, L.P. · CIK 0001871642 · 10% owner H&F Copper Holdings VIII GP, LLC · CIK 0001871641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F1 · price: On June 14, 2024, Resideo Technologies, Inc. ("Resideo") acquired the Issuer pursuant to an Agreement and Plan of Merger, dated as of April 14, 2024 (the "Merger Agreement"), by and among the Issuer, Resideo and Pop Acquisition Inc., a Delaware corporation and a wholly owned subsidiary of Resideo ("Merger Sub"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer surviving the Merger as a wholly owned subsidiary of Resideo. At the Effective Time (as defined in the Merger Agreement), each issued and outstanding share of Issuer common stock, par value $0.01 per share (the "Common Stock") (other than certain Excluded Shares (as defined in the Merger Agreement)) automatically converted into the right to receive $10.75 per share in cash, without interest and less any applicable withholding taxes. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F8 · ownership.nature: Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of H&F VIII has investment discretion over the shares held by the H&F VIII Funds and Copper Holdings. Each of the members of the board of directors disclaims beneficial ownership of such shares, except to the extent of any respective pecuniary interest therein. Read SEC document
December 08, 2021 Filed Dec 8, 2021 22:05 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	157,138	$47.50	$7,464,055.00	Disclosure SEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 9 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F10 · ownership.nature: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 22:05 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	934,469	$47.50	$44,387,277.50	Disclosure SEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 8 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F9 · ownership.nature: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 22:05 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	3,021,286	$47.50	$143,511,085.00	Disclosure SEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 7 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F8 · ownership.nature: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 22:05 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	15,987,409	$47.50	$759,401,927.50	Disclosure SEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 6 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F7 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 22:05 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	35,622,429	$47.50	$1,692,065,377.50	Disclosure SEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 5 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F6 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 22:05 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	359,372	$47.50	$17,070,170.00	Disclosure SEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 4 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F5 · ownership.nature: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 22:05 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	3,630,740	$47.50	$172,460,150.00	Disclosure SEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 3 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F4 · ownership.nature: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 22:05 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	20,244,387	$47.50	$961,608,382.50	Disclosure SEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 2 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F3 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
December 08, 2021 Filed Dec 8, 2021 22:05 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	52,884,036	$47.50	$2,511,991,710.00	Disclosure SEC source: 0000899243-21-047360 · doc4.xml · nonDerivative · entry 1 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 F1 · kind: On December 8, 2021, Thermo Fisher Scientific Inc., a Delaware corporation ("Buyer"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Powder Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of Buyer ("Merger Sub"), dated as of April 15, 2021 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the "Merger"). At the effective time of the Merger, each issued and outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $47.50 in cash. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 20:48 UTC	PPD, Inc. PPD · Entity 15247	GiftCommon Stock	127,867	$0.00	$0.00	Disclosure SEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 11 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F13 · ownership.direct: These shares of Common Stock were received by Mr. Thorpe in connection with pro rata distributions made by HFCP VII described above and were transferred as a charitable donation upon receipt. Read SEC document
September 21, 2020 Filed Sep 23, 2020 20:48 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	30,264	$31.28	$946,733.58	Disclosure SEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 10 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 157,138 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F10 · ownership.nature: Reflects securities directly held by H&F Associates VIII, L.P. ("H&F VIII Associates", and together with HFCP VIII, HFCP VIII Parallel, HFCP VIII Parallel-A and H&F VIII Executives, the "H&F VIII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 20:48 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	179,980	$31.28	$5,630,224.35	Disclosure SEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 9 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 934,469 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F9 · ownership.nature: Reflects securities directly held by H&F Executives VIII, L.P. ("H&F VIII Executives"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 20:48 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	581,903	$31.28	$18,203,380.60	Disclosure SEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 8 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,021,286 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F8 · ownership.nature: Reflects securities directly held by HFCP VIII (Parallel-A), L.P. ("HFCP VIII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 20:48 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	3,079,193	$31.28	$96,324,855.02	Disclosure SEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 7 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 15,987,409 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F7 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII (Parallel), L.P. ("HFCP VIII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 20:48 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	6,860,919	$31.28	$214,626,698.62	Disclosure SEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 6 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 35,622,429 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F6 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VIII, L.P. ("HFCP VIII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 20:48 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	69,215	$31.28	$2,165,218.24	Disclosure SEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 5 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 359,372 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F5 · ownership.nature: Reflects securities directly held by H&F Executives VII, L.P. ("H&F VII Executives", and together with HFCP VII, HFCP VII Parallel and HFCP VII Parallel-A, the "H&F VII Funds"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 20:48 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	699,284	$31.28	$21,875,351.73	Disclosure SEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 4 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,630,740 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F4 · ownership.nature: Reflects securities directly held by HFCP VII (Parallel-A), L.P. ("HFCP VII Parallel-A"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 20:48 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	3,899,092	$31.28	$121,973,345.49	Disclosure SEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 3 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 20,244,387 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F3 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII (Parallel), L.P. ("HFCP VII Parallel"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 20:48 UTC	PPD, Inc. PPD · Entity 15247	OtherCommon Stock	883,200	$0.00	$0.00	Disclosure SEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 2 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 52,884,036 F12 · kind: Represents in-kind distributions of shares of Common Stock previously held by HFCP VII to certain of its direct and indirect partners for the sole purpose of charitable giving. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document
September 21, 2020 Filed Sep 23, 2020 20:48 UTC	PPD, Inc. PPD · Entity 15247	SaleCommon Stock	9,302,325	$31.28	$290,999,981.81	Disclosure SEC source: 0000899243-20-026096 · doc4.xml · nonDerivative · entry 1 H&F Corporate Investors VIII, Ltd. · CIK 0001767563 · 10% owner Hellman & Friedman Investors VIII, L.P. · CIK 0001801252 · 10% owner Hellman & Friedman Capital Partners VIII, L.P. · CIK 0001618933 · 10% owner Hellman & Friedman Capital Partners VIII (Parallel), L.P. · CIK 0001618902 · 10% owner HFCP VIII (Parallel - A), L.P. · CIK 0001618909 · 10% owner H&F Executives VIII, L.P. · CIK 0001619367 · 10% owner H&F Associates VIII, L.P. · CIK 0001621509 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 53,767,236 F1 · price: This amount represents the $32.25 secondary public offering price per share of the Common Stock of the Issuer less the underwriting discount of $0.9675 per share. F2 · ownership.nature: Reflects securities directly held by Hellman & Friedman Capital Partners VII, L.P. ("HFCP VII"). F11 · ownership.nature: Hellman & Friedman Investors VII, L.P. ("H&F Investors VII") is the general partner of each of the H&F VII Funds. H&F Corporate Investors VII, Ltd. ("H&F VII") is the general partner of H&F Investors VII. Hellman & Friedman Investors VIII, L.P. ("H&F Investors VIII") is the general partner of each of the H&F VIII Funds. H&F Corporate Investors VIII, Ltd. ("H&F VIII") is the general partner of H&F Investors VIII. A three member board of directors of each of H&F VII and H&F VIII has investment discretion over the shares held by the H&F VII Funds and the H&F VIII Funds, respectively. Allen R. Thorpe, a member of the board of directors of PPD, Inc. is a member of the boards of directors of H&F VII and H&F VIII. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.